Another study found significant differences between FGF1 mRNA level and overall survival in 42 patients with advanced stage high-grade serous ovarian carcinoma, suggesting that FGF1 amplification may be a poor prognostic factor [9]. Here, FGF1 is linked to ovarian serous carcinoma.